Patients
& Families

Our commitment to the patient community encompasses not just our efforts to develop potentially curative therapies, but to understand the needs and experiences of those we serve.

Resources

Advocacy Partners

Gamida Cell is also proud to be working alongside advocacy organizations to serve the patient community. We invite you to visit the websites below for additional resources:

PATIENT STORIES

Read about patients’ personal journeys through cancer diagnosis and treatment.

These are two patients, and results may not be indicative. Please note that omidubicel and GDA-201 are investigational and safety and efficacy have not been established by any agency.

Patient Voices: Stacey Khoury
Years After Transplant, Stacey Khoury Reflects on Her Journey

Read about Stacey’s personal journey through cancer diagnosis and treatment.

Meet Stacey
Patient Voices: Wayne Altenbernd
After Treatment for Lymphoma, Wayne Alternbernd Discusses his Journey

Read about Wayne’s experience in a clinical study.

Meet Wayne

CLINICAL TRIALS

Gamida Cell is developing advanced cell therapies for the treatment of blood cancers and serious blood diseases. For information about ongoing clinical trials of our investigational therapies, please view our pipeline.

How Gamida Cell Uses and Maintains Information Collected from its Clinical Trials

Gamida Cell processes and transfers personal data, through the investigational sites, in accordance with all applicable federal regulations pertaining to investigational drugs (Health Insurance Portability and Accountability Act of 1996 and its implementing regulations (“HIPAA”)), and to the applicable Data Protection and Privacy Laws – Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of Personal Data and on the free movement of such data, and repealing Directive 95/ 46/EC : the General Data Protection Regulation (“GDPR”); UK Data Protection Act 2018 (amended 2020) (the “Data Protection Act”), which is the UK’s implementation of the GDPR.

The data shared with Gamida Cell is protected using a code specifically assigned so that the study participant cannot be identified. This applies to any and all activities involving the processing of Personal Data (including Personal Data made public by the Data Subject) by or on behalf of Gamida Cell, and in any format whether electronic or paper, regardless of storage location and means.

Study records that identify you will be kept confidential as required by law and will not be made publicly available. Whilst the information and data resulting from this study may be presented at scientific meetings or published in a scientific journal, your identity will not be revealed.

A description of the clinical trial is available on http://www.ClinicalTrials.gov, as required by U.S. Law.  This website will not include information that can identify you.  At most, the website will include a summary of the results.  You can search this website at any time.

VIEW OUR PIPELINE